654 related articles for article (PubMed ID: 17569868)
1. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
[TBL] [Abstract][Full Text] [Related]
2. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.
Watts BA; George T; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F103-F115. PubMed ID: 28356284
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
Embry CA; Franchi L; Nuñez G; Mitchell TC
Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A.
Stark RJ; Choi H; Koch SR; Fensterheim BA; Lamb FS; Sherwood ER
Clin Sci (Lond); 2016 Mar; 130(6):451-61. PubMed ID: 26669797
[TBL] [Abstract][Full Text] [Related]
5. TLR4-mediated pro-inflammatory dendritic cell differentiation in humans requires the combined action of MyD88 and TRIF.
Kolanowski ST; Dieker MC; Lissenberg-Thunnissen SN; van Schijndel GM; van Ham SM; ten Brinke A
Innate Immun; 2014 May; 20(4):423-30. PubMed ID: 23941760
[TBL] [Abstract][Full Text] [Related]
6. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1.
Watts BA; Tamayo E; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F705-F719. PubMed ID: 31241993
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria.
Chilton PM; Hadel DM; To TT; Mitchell TC; Darveau RP
Infect Immun; 2013 Sep; 81(9):3317-25. PubMed ID: 23798540
[TBL] [Abstract][Full Text] [Related]
9. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
10. TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion.
Gandhapudi SK; Chilton PM; Mitchell TC
PLoS One; 2013; 8(2):e56855. PubMed ID: 23457630
[TBL] [Abstract][Full Text] [Related]
11. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
[TBL] [Abstract][Full Text] [Related]
13. The TLR4-TRIF pathway can protect against the development of experimental allergic asthma.
Shalaby KH; Al Heialy S; Tsuchiya K; Farahnak S; McGovern TK; Risse PA; Suh WK; Qureshi ST; Martin JG
Immunology; 2017 Sep; 152(1):138-149. PubMed ID: 28502093
[TBL] [Abstract][Full Text] [Related]
14. The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes.
Hernandez A; Bohannon JK; Luan L; Fensterheim BA; Guo Y; Patil NK; McAdams C; Wang J; Sherwood ER
J Leukoc Biol; 2016 Dec; 100(6):1311-1322. PubMed ID: 27354411
[TBL] [Abstract][Full Text] [Related]
15. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A.
Cekic C; Casella CR; Eaves CA; Matsuzawa A; Ichijo H; Mitchell TC
J Biol Chem; 2009 Nov; 284(46):31982-91. PubMed ID: 19759006
[TBL] [Abstract][Full Text] [Related]
16. MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid A stimulation of TLR4.
Cekic C; Casella CR; Sag D; Antignano F; Kolb J; Suttles J; Hughes MR; Krystal G; Mitchell TC
J Immunol; 2011 Apr; 186(7):3858-65. PubMed ID: 21339365
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
Gavin AL; Hoebe K; Duong B; Ota T; Martin C; Beutler B; Nemazee D
Science; 2006 Dec; 314(5807):1936-8. PubMed ID: 17185603
[TBL] [Abstract][Full Text] [Related]
18. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
19. A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses.
Xiao L; Kim J; Lim M; Dai B; Yang L; Reed SG; Baltimore D; Wang P
Vaccine; 2012 Mar; 30(15):2570-81. PubMed ID: 22314134
[TBL] [Abstract][Full Text] [Related]
20. Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells.
Kolanowski ST; Lissenberg-Thunnissen SN; Emal D; van Ham SM; Ten Brinke A
Inflamm Res; 2016 Jun; 65(6):449-58. PubMed ID: 26994069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
